Joint Pain: What the Pattern Tells Your Doctor

Pattern-Based Diagnosis

Key Blood Tests

• CRP / ESR: inflammation markers
• Uric acid: raised in gout
• Rheumatoid factor (RF) + Anti-CCP: RA diagnosis
• ANA: screen for lupus and autoimmune disease
• Joint X-ray: bony erosions, joint space narrowing
• Synovial fluid analysis: gold standard for gout vs septic arthritis

How blood tests help classify joint disease

Blood tests cannot diagnose joint disease alone, but they narrow the differential significantly when interpreted alongside the clinical pattern.

Inflammatory markers: CRP and ESR

C-reactive protein (CRP) rises within 6–12 hours of inflammation and correlates with disease activity in rheumatoid arthritis and other inflammatory arthritides. Erythrocyte sedimentation rate (ESR) is slower to rise and fall but useful for monitoring chronic conditions. In osteoarthritis, CRP and ESR are typically normal or only mildly elevated; a high CRP in a patient with joint pain points toward an inflammatory or infective cause.

Rheumatoid factor and anti-CCP antibodies

Rheumatoid factor (RF) is positive in roughly 70–80% of people with RA but is not specific: it is also raised in Sjögren's syndrome, hepatitis C, and even healthy older adults. Anti-cyclic citrullinated peptide (anti-CCP) antibodies are far more specific for RA (specificity ~98%), making them the preferred confirmatory test. The 2010 ACR/EULAR RA Classification Criteria weight both RF and anti-CCP, with high-positive titres scoring more heavily.¹

Uric acid in gout

A serum uric acid level above 360 µmol/L (6 mg/dL) is the treatment threshold for gout according to EULAR guidelines. However, uric acid can be normal during an acute attack (it falls as crystals deposit in the joint), so a normal level during an acute flare does not exclude gout. The gold standard remains synovial fluid analysis showing negatively birefringent monosodium urate crystals under polarised light microscopy.

ANA and autoimmune screening

Antinuclear antibodies (ANA) are the initial screen for systemic lupus erythematosus (SLE) and other connective tissue diseases. A positive ANA at ≥1:80 titre in a patient with joint pain, fatigue, and photosensitive rash warrants further testing (anti-dsDNA, anti-Sm, complement levels). ANA positivity alone, in the absence of symptoms, is common in the general population and does not indicate disease.

When to consider referral to rheumatology

Early referral (ideally within 3 months of symptom onset) is recommended for any patient with suspected inflammatory arthritis. Studies show that disease-modifying treatment started within the first 3 months of RA onset achieves remission far more often than later treatment, a principle known as the "window of opportunity."

References

Sources cited on this page. PubMed links open the original abstract.

1. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid Arthritis Classification Criteria. Ann Rheum Dis. 2010;69(9):1580–1588. PMID 20699241 · doi:10.1136/ard.2010.138461